Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice

The therapeutic sc"enario of metastatic renal cell cancer (mRCC) has noticeably increased, ranging from the most studied molecular target therapies to those most recently introduced, up to immune checkpoint inhibitors (ICIs). The most recent clinical trials with an ICI-based combination of mole...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Roberto, Michela, Botticelli, Andrea, Panebianco, Martina, Aschelter, Anna Maria, Gelibter, Alain, Ciccarese, Chiara, Minelli, Mauro, Nuti, Marianna, Santini, Daniele, Laghi, Andrea, Tomao, Silverio, Marchetti, Paolo
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100507/
https://ncbi.nlm.nih.gov/pubmed/33968762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.657639
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars